Efficient depletion of alloreactive donor T lymphocytes based on expression of two activation-induced antigens (CD25 and CD69)

British Journal of Haematology

Volumn 109, Issue 3, 2000, Pages 644-651

  Fehse, Boris ^a   Frerk, Oliver ^a   Goldmann, Michal ^a   Bulduk, Maria ^a   Zander, Axel R ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Alloreactivity; CD25; CD69; Magnetic cell sorting; T cell depletion

Indexed keywords

ANTIBODY; CD69 ANTIGEN; INTERLEUKIN 2 RECEPTOR;

ADOPTIVE TRANSFER; ALLOIMMUNITY; ALLOTRANSPLANTATION; ANTIGEN EXPRESSION; ARTICLE; CELL CULTURE; CELL SELECTION; DONOR; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; LYMPHOCYTE DEPLETION; PRIORITY JOURNAL; T LYMPHOCYTE;

ADOPTIVE TRANSFER; ANTIBODIES; ANTIGENS, CD; ANTIGENS, CD26; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CELL LINE; CELL SEPARATION; CELLS, CULTURED; GRAFT VS HOST DISEASE; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; MAGNETICS; STATISTICS, NONPARAMETRIC; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 0034094236     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.02074.x     Document Type: Article

References (30)

1. Antin, J.H., Bierer, B.E., Smith, B.R., Ferrara, J., Guinan, E.C., Sieff, C., Golan, D.E., Macklis, R.M., Tarbell, N.J., Lynch, E., Reichert, T.A., Blythman, H., Bouloux, C., Rappeport, J.M., Burakoff, S.J. & Weinstein, H.J. (1991) Selective depletion of bone marrow T lymphocytes with anti-CD5 monoclonal antibodies: effective prophylaxis for graft-versus-host disease in patients with hematologic malignancies. Blood, 78, 2139-2149.
2. Ayuk, F.A., Li, Z., Kühlcke, K., Lindemann, C., Schade, U.M., Eckert, H.-G., Zander, A.R. & Fehse, B. (1999) Establishment of an optimised gene transfer protocol for human primary T lymphocytes according to clinical requirements. Gene Therapy, 6, 1788-1792.
3. Barrett, A.J. & Malkovska, V. (1996) Graft-versus-leukaemia: understanding and using the alloimmune response to treat haematogical malignancies. British Journal of Haematology, 93, 754-761.
4. Bonini, C., Ferrari, G., Verzeletti, S., Servida, P., Zappone, E., Ruggieri, L., Ponzoni, M., Rossini, S., Mavilio, F., Traversari, C. & Bordignon, C. (1997) HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. Science, 276, 1719-1724.
5. Caruso, A., Licenziati, S., Corulli, M., Canaris, A.D., De Francesco, M.A., Florentini, S., Peroni, L., Fallacara, F., Dima, F., Balsari, A. & Turano, A. (1997) Flow cytometric analysis of activation markers on stimulated T cells and their correlation with cell proliferation. Cytometry, 27, 71-76.
6. Cavazzana-Calvo, M., Fromont, C., Le Deist, F., Lusardi, M., Coulombel, L., Derocq, J.-M., Gerota, I., Griscelli, C. & Fischer, A. (1990) Specific elimination of alloreactive T cells by an anti-interleukin-2 receptor b chain-specific immunotoxin. Transplantation, 50, 1-7.
7. Champlin, R., Ho, W., Gajewski, J., Feig, S., Burnison, M., Holley, G., Greenberg, P., Lee, K., Schmid, I., Giorgi, J., Yam, P., Petz, L., Winston, D., Warner, N. & Reichert, T. (1990) Selective depletion of CD8+ T lymphocytes for prevention of graft-versus-host disease after allogeneic bone marrow transplantation. Blood, 76, 418-423.
8. Craston, R., Koh, M., McDermott, A., Ray, N., Prentice, H.G. & Lowdell, M.W. (1997) Temporal dynamics of CD69 expression on lymphoid cells. Journal of Immunological Methods, 209, 37-45.
9. Datta, A.R., Barrett, A.J., Jiang, Y.Z., Guimraes, A., Mavroudis, D.A., van Rhee, F., Gordon, A.A. & Madrigal, A. (1994) Distinct T-cell populations distinguish chronic myeloid leukaemia cells from lymphocytes in the same individual: a model for separating GVHD from GVL reactions. Bone Marrow Transplantation, 14, 517-524.
10. + cells transduced with retroviral vectors containing an intracytoplasmatically truncated version of the human low-affinity nerve growth factor receptor (ΔLNGFR) gene. Human Gene Therapy, 8, 1815-1824.
11. Garderet, L., Snell, V., Przepiorka, D., Schenk, T., Lu, J.G., Marini, F., Gluckman, E., Andreeff, M. & Champlin, R.E. (1999) Effective depletion of alloreactive lymphocytes from peripheral blood mononuclear cell preparations. Transplantation, 67, 124-130.
12. Girolomoni, G. & Ricciardi-Castagnoli, P. (1997) Dendritic cells hold promise for immunotherapy. Immunology Today, 18, 102-104.
13. + lymphocytes in the marrow graft. Bone Marrow Transplantation, 23, 443-450.
14. Horowitz, M.M., Gale, R.P., Sondel, P.M., Goldman, J.M., Kersey, J., Kolb, H.-J., Rimm, A.A., Ringdén, O., Rozman, C., Speck, B., Truitt, R.L., Zwaan, F.E. & Bortin, M.M. (1990) Graft-versus-leukemia reactions after bone marrow transplantation. Blood, 75, 555-562.
15. Koh, M.B., Prentice, H.G. & Lowdell, M.W. (1999) Selective removal of alloreactive cells from haematopoietic stem cell grafts: graft engineering for GVHD prophylaxis. Bone Marrow Transplantation, 23, 1071-1079.
16. Kolb, H.J., Mittermüller, J., Clemm, Ch., Holler, E., Ledderose, G., Brehm, G., Heim, M. & Wilmanns, W. (1990) Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood, 76, 2462-2465.
17. Kolb, HJ., Schattenberg, A., Goldman, J.M., Hertenstein, B., Jacobsen, N., Arcese, W., Ljungman, P., Ferrant, A., Verdonk, L., Niederwieser, D., van Rhee, F., Mittermüller, J., de Witte, T., Holler, E. & Ansari, H. (1995) Graft-versus-leukemia effect of donor lymphocyte transfusion in marrow grafted patients. Blood, 86, 2041-2050.
18. Mavroudis, D.A., Jiang, Y.Z., Hensel, N., Lewalle, P., Courielle, D., Kreitman, R., Pastan, I. & Barrett, A.J. (1996) Specific depletion of alloreactivity against haplotype mismatched related individuals by a recombinant immunotoxin: a new approach to graft-versus-host disease prophylaxis in haploidentical bone marrow transplantation. Bone Marrow Transplantation, 17, 793-799.
19. Mavroudis, D.A., Dermime, S., Molldrem, J., Jiang, Y.Z., Raptis, A., van Rhee, F., Hensel, N., Fellowes, V., Eliopoulos, G. & Barrett, J. (1998) Specific depletion of alloreactive T cells in HLA-identical siblings: a method for separating graft-versus-host and graft-versus-leukaemia reactions. British Journal of Haematology, 101, 565-570.
20. Müther, H., Kühlcke, K., Gessner, A., Abdallah, S. & Lother, H. (1994) Homodimeric murine interleukin-3 agonists indicate that ligand dimerization is important for high-affinity receptor complex formation. Growth Factors, 10, 17-27.
21. Papadopoulos, E.B., Ladanyi, M., Emanuel, D., Mackinnon, S., Boulad, F., Carabasi, M.H., Castro-Malaspina, H., Childs, B.H., Gillio, A.P., Small, T.N., Young, J.W., Kernan, N.A. & O'Reilly, R.J. (1994) Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. New England Journal of Medicine, 330, 1185-1191.
22. Rencher, S.D., Houston, J.A., Lockey, T.D. & Hurwitz, J.L. (1996) Eliminating GvH potential from T cell immunotherapeutic populations. Bone Marrow Transplantation, 18, 415-420.
23. Reisner, Y., Kapoor, N., Kirkpatrick, D., Pollack, M.S., Dupont, B., Good, R.A. & O'Reilly, R.J. (1981) Transplantation for acute leukaemia with HLA-A and B nonidentical parental marrow cells fractionated with soybean agglutinin and sheep red blood cells. Lancet, 2, 327-331.
24. Riddell, S.R., Watanabe, K.S., Goodrich, J.M., Li, C.R., Agha, M.E. & Greenberg, P.D. (1992) Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science, 257, 238-241.
25. Sallusto, F. & Lanzavecchia, A. (1994) Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin-4 and downregulated by tumor necrosis factor-alpha. Journal of Experimental Medicine, 179, 1109-1118.
26. Soiffer, R.J., Murray, C., Mauch, P., Anderson, K.C., Freedman, A.S., Rabinowe, S.N., Takvorian, T., Robertson, M.J., Spector, N., Gonin, R., Miller, K.B., Rudders, R.A., Freeman, A., Blake, K., Coral, F., Nadler, L.M. & Ritz, J. (1992) Prevention of graft-versus-host disease by selective depletion of CD6-positive T lymphocytes from donor bone marrow. Journal of Clinical Oncology, 10, 1191-1200.
27. Sullivan, K.M., Storb, R., Buckner, C.D., Fefer, A., Fisher, L., Weiden, P.L., Witherspoon, R.P., Appelbaum, F.R., Banaji, M., Hansen, J., Martin, P., Sanders, J.E., Singer, J. & Thomas, E.D. (1989) Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasms. New England Journal of Medicine, 320, 828-834.
28. Tiberghien, P., Reynolds, C.W., Keller, J., Spence, S., Deschaseaux, M., Certoux, J.M., Contassot, E., Murphy, W.J., Lyons, R., Chiang, Y., Hervé, P., Longo, D.L. & Ruscetti, F.W. (1994) Ganciclovir treatment of herpes simplex thymidine kinase-transduced primary T lymphocytes: an approach for specific in vivo T-cell depletion after bone marrow transplantation? Blood, 84, 1333-1341.
29. Truitt, R.L. & Atasoylu, A.A. (1991) Contribution of CD4+ and CD8+ T cells to graft-versus-host disease and graft-versus-leukemia reactivity after transplantation of MHC-compatible marrow. Bone Marrow Transplantation, 8, 51-58.
30. Wagner, J.E., Santos, G.W., Noga, S.J., Rowley, S.D., Davis, J., Vogelsang, G.B., Farmer, E.R., Zehnbauer, B.A., Saral, R. & Donnenberg, A.D. (1990) Bone marrow graft engineering by counterflow centrifugal elutriation: results of a phase I-II clinical trial. Blood, 75, 1370-1377.